University of PittsburghUniversity of Pittsburgh
Startups
TechnologiesStartupsExpress LicensesCollectionsChat with AI
Sign in
University of Pittsburgh

CellPlex Biosciences, Inc.

OverviewRequest InfoMore Like ThisExpress Licenses

Sector

Diagnostic

Therapeutic Areas

Immunology

Founders

Rakesh Sindhi

CellPlex Biosciences is developing precision tools to help transplanted organs last longer. Its platform examines gene activity in transplant tissue to identify the biological pathways driving rejection, with the goal of helping clinicians select anti-rejection treatments suited to each patient. Machine learning supports efforts to focus testing on the most informative genes. [1]

Founded by University of Pittsburgh transplant researcher Rakesh Sindhi, CellPlex builds on decades of research and tissue samples from UPMC's transplant program. By connecting molecular insights with treatment selection, the company aims to improve long-term organ protection and reduce the need for repeat transplantation. [2]

Discover More with AI